We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
MenzebachA, CassensU, Van AkenH, BookeM. Strategies to reduce perioperative blood loss related to non-surgical bleeding.Eur J Anaesthesiol2003; 20: 764–770.Google Scholar
HenryDA, MoxeyAJ, CarlessPA, et al. Desmopressin for minimizing perioperative allogenic blood transfusion.Cochrane Database of Systematic Reviews2001; 2: CD001884.Google Scholar
PorteRJ, LeebeekFW. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery.Drugs2002; 62: 2193–2211.Google Scholar
HiippalaST, MyllyläGJ, VahteraEM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates.Anesth Analg1995; 81: 360–365.Google Scholar
MardelSN, SaundersFM, AllenH, et al. Reduced clot quality of clot formation with gelatin based plasma substitutes.Br J Anaesth1998; 80: 204–207.Google Scholar
GerlachR, TölleF, RaabeA, et al. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased FXIII activity.Stroke2002; 33: 1618–1623.Google Scholar
WarrenBL, EidA, SingerP, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.J Am Med Assoc2001; 286: 1869–1878.Google Scholar